Okamoto, H., Dirks, N. L., Rosario, M., Hori, T., & Hibi, T. (2021). Population pharmacokinetics of vedolizumab in Asian and non-Asian patients with ulcerative colitis and Crohn’s disease. Intest Res.
Citación estilo ChicagoOkamoto, Hiroyuki, Nathanael L. Dirks, Maria Rosario, Tetsuharu Hori, y Toshifumi Hibi. "Population Pharmacokinetics of Vedolizumab in Asian and Non-Asian Patients With Ulcerative Colitis and Crohn’s Disease." Intest Res 2021.
Cita MLAOkamoto, Hiroyuki, et al. "Population Pharmacokinetics of Vedolizumab in Asian and Non-Asian Patients With Ulcerative Colitis and Crohn’s Disease." Intest Res 2021.
Precaución: Estas citas no son 100% exactas.